➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Merck
McKesson
AstraZeneca
Baxter

Last Updated: September 20, 2020

DrugPatentWatch Database Preview

Patent: 7,908,087

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,908,087
Title:Methods of identifying latent splice sites
Abstract: A method of identifying latent splice sites, the method comprising identifying at least one intronic in-frame stop codon located upstream of a 5\' splice site sequence being a latent splice site, thereby identifying latent splice sites.
Inventor(s): Sperling; Joseph (Jerusalem, IL), Sperling; Ruth (Jerusalem, IL)
Assignee: Yeda Research And Development Co. Ltd. (Rehovot, IL) Yissum Research Development Company of the Hebrew University of Jerusalem (Jerusalem, IL)
Application Number:10/505,884
Patent Claims:see list of patent claims

Details for Patent 7,908,087

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Yeda Research And Development Co. Ltd. (Rehovot, IL) Yissum Research Development Company of the Hebrew University of Jerusalem (Jerusalem, IL) 2039-02-26 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Yeda Research And Development Co. Ltd. (Rehovot, IL) Yissum Research Development Company of the Hebrew University of Jerusalem (Jerusalem, IL) 2039-02-26 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Yeda Research And Development Co. Ltd. (Rehovot, IL) Yissum Research Development Company of the Hebrew University of Jerusalem (Jerusalem, IL) 2039-02-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Johnson and Johnson
Boehringer Ingelheim
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.